Fatigue in Prevalent Haemodialysis Patients Predicts All-cause Mortality and Kidney Transplantation

被引:26
|
作者
Picariello, Federica [1 ]
Norton, Sam [1 ]
Moss-Morris, Rona [1 ]
Macdougall, Iain C. [2 ]
Chilcot, Joseph [1 ]
机构
[1] Kings Coll London, Inst Psychiat Psychol & Neurosci, Psychol Dept, Hlth Psychol Sect, 5th Floor,Bermondsey Wing,Guys Campus, London SE1 9RT, England
[2] Kings Coll Hosp London, Dept Renal Med, London, England
关键词
fatigue; vitality; dialysis; transplantation; survival; mortality; outcome; QUALITY-OF-LIFE; RENAL REPLACEMENT THERAPY; CLINICAL-PRACTICE GUIDELINE; COGNITIVE-BEHAVIOR THERAPY; DEPRESSIVE SYMPTOMS; HOSPITAL ANXIETY; DISEASE; SURVIVAL; DIALYSIS; RISK;
D O I
10.1093/abm/kay061
中图分类号
B84 [心理学];
学科分类号
04 ; 0402 ;
摘要
Background Fatigue affects between 49% and 92% of dialysis patients with considerable repercussions on their functioning and quality of life. Purpose To evaluate whether fatigue severity and its impact on functioning predict survival (all-cause mortality) and time to transplantation among in-centre haemodialysis patients. Methods As part of a prospective study of fatigue among in-centre haemodialysis patients, survival data were collected between April 2014 and August 2017. Fatigue severity was measured using the Chalder Fatigue Questionnaire (CFQ) and fatigue-related functional impairment using the Work and Social Adjustment Scale (WSAS). Sociodemographic, clinical, and psychological data were collected. The association between fatigue and outcomes was assessed using proportional hazard survival models, allowing for competing risks, and discrete-time survival models. All models were adjusted for relevant risk factors. Results The sample consisted of 174 haemodialysis patients. There were 37 deaths and 31 transplantations over 3 years. At 1,095 days (36 months), cumulative survival was 70.5% and the cumulative transplantation rate was 22.2%. In unadjusted models, fatigue was significantly associated with an increased risk of death (CFQ-continuous SHR = 1.06, 95% CI: 1.02 to 1.11; CFQ-dichotomous SHR = 2.18, 95% CI: 1.11 to 4.31; WSAS SHR = 1.03, 95% CI: 1.01 to 1.05) and decreased likelihood of transplantation (CFQ-continuous SHR = 0.92, 95% CI: 0.87 to 0.98; CFQ-dichotomous SHR = 0.33, 95% CI: 0.15 to 0.75; WSAS SHR = 0.96, 95% CI: 0.93 to 0.99). However, these associations ceased to be significant after controlling for covariates. Conclusions Fatigue was predictive of an increased risk of death and decreased likelihood of transplantation among patients, possibly through distress, impaired functioning, and its consequences, rather than clinical and inflammatory markers. Fatigued dialysis patients were more likely to die and less likely to get a transplant over 3 years, possibly because of the negative consequences of fatigue on mood and capacity to undertake everyday activities.
引用
收藏
页码:501 / 514
页数:14
相关论文
共 50 条
  • [21] Pupillary area predicts all-cause mortality in patients with cardiovascular disease
    Nozaki, K.
    Kamiya, K.
    Hamazaki, N.
    Matsuzawa, R.
    Ichikawa, T.
    Nakamura, T.
    Yamashita, M.
    Maekawa, E.
    Matsunaga, A.
    Tojo, M.
    Ako, J.
    EUROPEAN HEART JOURNAL, 2019, 40 : 1477 - 1477
  • [22] The Gamma Gap Predicts All-Cause Mortality in Chronic Dialysis Patients
    Avramovski, Petar J.
    Petlichkovski, Aleksandar
    Avramovska, Maja
    Ilkovska, Biljana
    Sotiroski, Kosta
    Nikleski, Zorica
    Sikole, Emilija
    INDIAN JOURNAL OF NEPHROLOGY, 2021, 31 (03) : 212 - 217
  • [23] Excess pressure integral predicts all-cause mortality of uremic patients
    Huang, J. T.
    Chen, C. H.
    Cheng, H. M.
    Sung, S. H.
    Yu, W. C.
    EUROPEAN HEART JOURNAL, 2016, 37 : 1333 - 1333
  • [24] Addition of Novel Biomarkers for Predicting All-Cause and Cardiovascular Mortality in Prevalent Hemodialysis Patients
    Yamashita, Kazuomi
    Mizuiri, Sonoo
    Nishizawa, Yoshiko
    Shigemoto, Kenichiro
    Doi, Shigehiro
    Masaki, Takao
    THERAPEUTIC APHERESIS AND DIALYSIS, 2018, 22 (01) : 31 - 39
  • [25] Faecal haemoglobin concentration predicts all-cause mortality
    Deding, Ulrik
    Kaalby, Lasse
    Steele, Robert
    Al-Najami, Issam
    Kobaek-Larsen, Morten
    Plantener, Eva
    Madsen, Jeppe B.
    Madsen, Jonna S.
    Bjorsum-Meyer, Thomas
    Baatrup, Gunnar
    EUROPEAN JOURNAL OF CANCER, 2023, 184 : 21 - 29
  • [26] SERUM CREATININE PREDICTS ALL-CAUSE AND CARDIOVASCULAR MORTALITY
    NARDO, CJ
    CRIQUI, MH
    LANGER, RD
    COUGHLIN, SS
    CIRCULATION, 1994, 89 (02) : 941 - 941
  • [27] Functional capacity but not ABI predicts all-cause mortality
    Yousefzai, Rayan
    Gornik, Heather L.
    Batizy, Lillian H.
    Kim, Esther S.
    Cerqueira, Manuel D.
    Jaber, Wael A.
    Houghtaling, Penny L.
    Venkatachalam, Sridhar
    Gray, Bruce H.
    Bartholomew, Jerry R.
    Blackstone, Eugene H.
    Shishehbor, Mehdi H.
    VASCULAR MEDICINE, 2011, 16 (03) : 230 - 231
  • [28] Infrarenal aortic diameter predicts all-cause mortality
    Norman, P
    Le, M
    Pearce, C
    Jamrozik, K
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2004, 24 (07) : 1278 - 1282
  • [29] C-reactive protein a marker for all-cause and cardiovascular mortality in haemodialysis patients
    Wanner, C
    Metzger, T
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2002, 17 : 29 - 32
  • [30] Associations between dynapenia, cardiovascular hospitalizations, and all-cause mortality among patients on haemodialysis
    Yoshikoshi, Shun
    Yamamoto, Shohei
    Suzuki, Yuta
    Imamura, Keigo
    Harada, Manae
    Osada, Shiwori
    Kamiya, Kentaro
    Matsunaga, Atsuhiko
    JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE, 2022, 13 (05) : 2417 - 2425